These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Pregnancy outcome after treatment with radioiodine for differentiated thyroid carcinoma. Balenović A; Vlasić M; Sonicki Z; Bodor D; Kusić Z Coll Antropol; 2006 Dec; 30(4):743-8. PubMed ID: 17243543 [TBL] [Abstract][Full Text] [Related]
7. [Blockade of iodine in thyroid cancer in known cases. Principles, effectiveness and actual cases]. Reiners C Nuklearmedizin; 2006; 45(3):97-100. PubMed ID: 16710503 [No Abstract] [Full Text] [Related]
8. Effects of I-131 therapy on gonads and pregnancy outcome in patients with thyroid cancer. Sioka C; Fotopoulos A Fertil Steril; 2011 Apr; 95(5):1552-9. PubMed ID: 21300333 [TBL] [Abstract][Full Text] [Related]
12. Correction. Thyroid cancer. CA Cancer J Clin; 1984; 34(5):299-302. PubMed ID: 6432242 [No Abstract] [Full Text] [Related]
13. [Role of the nuclear medicine in the treatment of thyroid carcinoma]. Börner W; Reiners C Med Klin; 1980 Jan; 75(2):80-7. PubMed ID: 7374606 [No Abstract] [Full Text] [Related]
14. Health outcomes of children fathered by patients treated with radioiodine for thyroid cancer. Garsi JP; Schlumberger M; Ricard M; Labbé M; Ceccarelli C; Schvartz C; Henry-Amar M; Bardet S; Rubino C; De Vathaire F Clin Endocrinol (Oxf); 2009 Dec; 71(6):880-3. PubMed ID: 19250267 [TBL] [Abstract][Full Text] [Related]
15. Complete disappearance of liver metastases in a patient with iodine-refractory differentiated thyroid cancer subjected to sorafenib re-challenge. Marotta V; Colao A; Faggiano A Endocrine; 2015 Dec; 50(3):824-5. PubMed ID: 25754914 [No Abstract] [Full Text] [Related]
16. Pregnancy outcome after diagnosis of differentiated thyroid carcinoma: no deleterious effect after radioactive iodine treatment. Chow SM; Yau S; Lee SH; Leung WM; Law SC Int J Radiat Oncol Biol Phys; 2004 Jul; 59(4):992-1000. PubMed ID: 15234032 [TBL] [Abstract][Full Text] [Related]
17. Long-term analysis of the efficacy and tolerability of sorafenib in advanced radio-iodine refractory differentiated thyroid carcinoma: final results of a phase II trial. Schneider TC; Abdulrahman RM; Corssmit EP; Morreau H; Smit JW; Kapiteijn E Eur J Endocrinol; 2012 Nov; 167(5):643-50. PubMed ID: 22918300 [TBL] [Abstract][Full Text] [Related]
18. A new age for recombinant human thyroid-stimulating hormone? Medvedec M J Nucl Med; 2009 May; 50(5):832; author reply 832-3. PubMed ID: 19372486 [No Abstract] [Full Text] [Related]
19. [Pregnancy in women with thyroid cancer treated with suppressive doses of L-thyroxine]. Jastrzebska H; Gietka-Czernel M; Zgliczyński S; Czech W; Lewartowska A; Debski R Wiad Lek; 2001; 54 Suppl 1():389-97. PubMed ID: 12182055 [TBL] [Abstract][Full Text] [Related]
20. Urinary iodine in patients with differentiated thyroid cancer (DTC) during L-thyroxine treatment. Michalik B; Roskosz J; Stanjek-Cichoracka A; Krajewska J; Kalemba M; Kochańska-Dziurowicz A; Jarząb B Endokrynol Pol; 2010; 61(5):458-61. PubMed ID: 21049458 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]